PROVEN TO HELP RESTORE SOME OF YOUR SKIN COLOR
OPZELURA was studied in two clinical trials for 6 months. Participants included 674 people (450 receiving OPZELURA, 224 receiving a cream with no active ingredient) aged 12 and older, who had received a diagnosis of nonsegmental vitiligo about 15 years prior, on average. Studies of OPZELURA included males and females, across a range of skin tones and races. Patients had vitiligo affecting up to 10% of their total body surface area (BSA). Phototherapy was not permitted during the trial. In clinical trials, OPZELURA was proven to help restore the skin's color over time. Individual results may vary.